(Q35722908)

9 August 2017

1 reference

title

Preventing type II diabetes mellitus (English)

1 reference

9 August 2017

0 references

L Michael Prisant

1

1 reference

9 August 2017

publication date

1 April 2004

1 reference

The Journal of Clinical Pharmacology

9 August 2017

published in

1 reference

9 August 2017

volume

44

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

406-413

1 reference

Diabetes trends in the U.S.: 1990-1998.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Impaired fasting glucose, blood pressure and cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Subclinical states of glucose intolerance and risk of death in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

The prevention or delay of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes")

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Principles for enhanced recruitment of subjects in a large clinical trial. the XENDOS (XENical in the prevention of Diabetes in Obese Subjects) study experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Ramipril and the development of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Lower diabetes risk with hormone replacement therapy: an encore for estrogen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Assessing the potential for alpha-glucosidase inhibitors in prediabetic states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

Cardiovascular morbidity and mortality associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263018

21 January 2018

Identifiers

DOI

10.1177/0091270004263018

1 reference

release_qqz2hifmxbhnvhtutyvuzzyjpa

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qqz2hifmxbhnvhtutyvuzzyjpa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference